Hsin-Hua Chou1, Lung-An Hsu2, Semon Wu3, Ming-Sheng Teng4, Yu-Chen Sun5, Yu-Lin Ko6. 1. Division of Cardiology, Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Taipei Branch; 2. The First Cardiovascular Division, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine; 3. Department of Life Science, Chinese Culture University; 4. Department of Medical Research, Buddhist Tzu Chi General Hospital, Taipei Branch; 5. Department of Laboratory Medicine, Chang Gung Memorial Hospital, Taipei; 6. Division of Cardiology, Department of Internal Medicine, Buddhist Tzu Chi General Hospital, Taipei Branch; ; Tzu Chi University College of Medicine, Hualien, Taiwan.
Abstract
BACKGROUND: Leptin and adiponectin are secreted from adipose tissue and exert opposing effects on C-reactive protein (CRP) levels and insulin resistance. As hypertrophic adipocytes secrete more leptin and less adiponectin, the leptin-to adiponectin ratio (LAR) has been proposed as a useful measure of insulin resistance and vascular risk. We investigated whether LAR may serve as a better predictor than either leptin or adiponectin alone for low-grade inflammation and insulin resistance independent of obesity in a non-diabetic Taiwanese population. METHODS: This study included 568 non-diabetic Taiwanese individuals (297 men, 271 women). CRP, leptin and adiponectin were measured using enzyme-linked immunosorbent assay. The degree of insulin resistance was determined using the homeostasis model assessment of insulin resistance (HOMA-IR). RESULTS: In the receiver operator characteristic analysis, the area under the curve of LAR in predicting individuals with elevated CRP and insulin resistance was significantly greater than that for either leptin (p = 0.0035 vs. elevated CRP, p < 0.0001 vs. insulin resistance) or adiponectin alone (p = 0.0131 vs. elevated CRP, p = 0.0006 vs. insulin resistance), suggesting that LAR might be a better predictor of individuals with low grade inflammation and insulin resistance. In the multivariable analysis adjusted for age, gender, smoking status, and components of metabolic syndrome, LAR was still strongly associated with levels of CRP (p < 0.001, all participants; p = 0.002, nonobese individuals; p < 0.001, obese individuals) and HOMA-IR index (p < 0.001, all participants, obese and nonobese individuals). CONCLUSIONS: The LAR is related to low grade inflammation and insulin resistance independent of obesity in non-diabetic Taiwanese, and the strength of associations between LAR with CRP and HOMA-IR are greater than the association with leptin or adiponectin alone. KEY WORDS: Adiponectin; C-reactive protein; Insulin resistance; Leptin; Obesity.
BACKGROUND:Leptin and adiponectin are secreted from adipose tissue and exert opposing effects on C-reactive protein (CRP) levels and insulin resistance. As hypertrophic adipocytes secrete more leptin and less adiponectin, the leptin-to adiponectin ratio (LAR) has been proposed as a useful measure of insulin resistance and vascular risk. We investigated whether LAR may serve as a better predictor than either leptin or adiponectin alone for low-grade inflammation and insulin resistance independent of obesity in a non-diabetic Taiwanese population. METHODS: This study included 568 non-diabetic Taiwanese individuals (297 men, 271 women). CRP, leptin and adiponectin were measured using enzyme-linked immunosorbent assay. The degree of insulin resistance was determined using the homeostasis model assessment of insulin resistance (HOMA-IR). RESULTS: In the receiver operator characteristic analysis, the area under the curve of LAR in predicting individuals with elevated CRP and insulin resistance was significantly greater than that for either leptin (p = 0.0035 vs. elevated CRP, p < 0.0001 vs. insulin resistance) or adiponectin alone (p = 0.0131 vs. elevated CRP, p = 0.0006 vs. insulin resistance), suggesting that LAR might be a better predictor of individuals with low grade inflammation and insulin resistance. In the multivariable analysis adjusted for age, gender, smoking status, and components of metabolic syndrome, LAR was still strongly associated with levels of CRP (p < 0.001, all participants; p = 0.002, nonobese individuals; p < 0.001, obese individuals) and HOMA-IR index (p < 0.001, all participants, obese and nonobese individuals). CONCLUSIONS: The LAR is related to low grade inflammation and insulin resistance independent of obesity in non-diabetic Taiwanese, and the strength of associations between LAR with CRP and HOMA-IR are greater than the association with leptin or adiponectin alone. KEY WORDS: Adiponectin; C-reactive protein; Insulin resistance; Leptin; Obesity.
Authors: Anna M Wolf; Dominik Wolf; Holger Rumpold; Barbara Enrich; Herbert Tilg Journal: Biochem Biophys Res Commun Date: 2004-10-15 Impact factor: 3.575
Authors: E Bonora; S Kiechl; J Willeit; F Oberhollenzer; G Egger; G Targher; M Alberiche; R C Bonadonna; M Muggeo Journal: Diabetes Date: 1998-10 Impact factor: 9.461
Authors: F M Finucane; J Luan; N J Wareham; S J Sharp; S O'Rahilly; B Balkau; A Flyvbjerg; M Walker; K Højlund; J J Nolan; D B Savage Journal: Diabetologia Date: 2009-09-12 Impact factor: 10.122
Authors: T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki Journal: Nat Med Date: 2002-10-07 Impact factor: 53.440
Authors: Clarisse Noël A Ayina; Francky Teddy A Endomba; Samuel Honoré Mandengue; Jean Jacques N Noubiap; Laurent Serge Etoundi Ngoa; Philippe Boudou; Jean-François Gautier; Jean Claude Mbanya; Eugene Sobngwi Journal: Diabetol Metab Syndr Date: 2017-09-05 Impact factor: 3.320
Authors: D L Tahapary; K de Ruiter; I Martin; E A T Brienen; L van Lieshout; Y Djuardi; C C Djimandjaja; J J Houwing-Duistermaat; P Soewondo; E Sartono; T Supali; J W A Smit; M Yazdanbakhsh Journal: Nutr Diabetes Date: 2017-10-16 Impact factor: 5.097
Authors: Ijeoma M Muo; Sandra D MacDonald; Ritu Madan; Sung-Jun Park; Ahmed M Gharib; Pedro E Martinez; Mary F Walter; Shanna B Yang; Justin A Rodante; Amber B Courville; Peter J Walter; Hongyi Cai; Michael Glicksman; Gioia M Guerrieri; Rivka R Ben-Dor; Ronald Ouwerkerk; Stephanie Mao; Jay H Chung Journal: Diabetes Metab Syndr Obes Date: 2019-05-27 Impact factor: 3.168
Authors: J A Rausch; S Gillespie; T Orchard; A Tan; J C McDaniel Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2021-05-24 Impact factor: 3.015